

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 9.47504906 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 9.47504906 |
| 3 | fatty acid elongation (GO:0030497) | 7.16252064 |
| 4 | * ensheathment of neurons (GO:0007272) | 6.75619427 |
| 5 | * axon ensheathment (GO:0008366) | 6.75619427 |
| 6 | * myelination (GO:0042552) | 6.74785649 |
| 7 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.56133748 |
| 8 | L-amino acid import (GO:0043092) | 5.09461048 |
| 9 | cholesterol biosynthetic process (GO:0006695) | 5.08458455 |
| 10 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.03173633 |
| 11 | activated T cell proliferation (GO:0050798) | 4.94704599 |
| 12 | regulation of collateral sprouting (GO:0048670) | 4.84973243 |
| 13 | oligodendrocyte differentiation (GO:0048709) | 4.77242726 |
| 14 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.71425815 |
| 15 | amino acid import (GO:0043090) | 4.60330714 |
| 16 | adhesion of symbiont to host cell (GO:0044650) | 4.53436133 |
| 17 | virion attachment to host cell (GO:0019062) | 4.53436133 |
| 18 | synaptic vesicle maturation (GO:0016188) | 4.45523087 |
| 19 | sterol biosynthetic process (GO:0016126) | 4.40850957 |
| 20 | creatine metabolic process (GO:0006600) | 4.34346856 |
| 21 | glycerophospholipid catabolic process (GO:0046475) | 4.31732143 |
| 22 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.30605341 |
| 23 | postsynaptic membrane organization (GO:0001941) | 4.21997383 |
| 24 | * substantia nigra development (GO:0021762) | 4.16105183 |
| 25 | response to methylmercury (GO:0051597) | 4.14618833 |
| 26 | myelin maintenance (GO:0043217) | 4.06188955 |
| 27 | negative regulation of neurotransmitter transport (GO:0051589) | 4.05745325 |
| 28 | presynaptic membrane assembly (GO:0097105) | 4.02763846 |
| 29 | eye photoreceptor cell differentiation (GO:0001754) | 4.00891812 |
| 30 | photoreceptor cell differentiation (GO:0046530) | 4.00891812 |
| 31 | neuron cell-cell adhesion (GO:0007158) | 3.97447930 |
| 32 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.92456163 |
| 33 | transmission of nerve impulse (GO:0019226) | 3.91916489 |
| 34 | astrocyte development (GO:0014002) | 3.91586888 |
| 35 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.84972204 |
| 36 | synaptic vesicle exocytosis (GO:0016079) | 3.83072148 |
| 37 | muscle filament sliding (GO:0030049) | 3.81779950 |
| 38 | actin-myosin filament sliding (GO:0033275) | 3.81779950 |
| 39 | presynaptic membrane organization (GO:0097090) | 3.77592859 |
| 40 | isoprenoid biosynthetic process (GO:0008299) | 3.77263283 |
| 41 | negative regulation of axonogenesis (GO:0050771) | 3.69713010 |
| 42 | import into cell (GO:0098657) | 3.69614716 |
| 43 | regulation of synapse structural plasticity (GO:0051823) | 3.66666878 |
| 44 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.65485938 |
| 45 | negative regulation of axon extension (GO:0030517) | 3.65026159 |
| 46 | negative regulation of protein localization to cell surface (GO:2000009) | 3.58906272 |
| 47 | positive regulation of actin filament depolymerization (GO:0030836) | 3.54944120 |
| 48 | asymmetric protein localization (GO:0008105) | 3.51842010 |
| 49 | neuronal ion channel clustering (GO:0045161) | 3.50087378 |
| 50 | glutamate secretion (GO:0014047) | 3.44021490 |
| 51 | adhesion of symbiont to host (GO:0044406) | 3.42186230 |
| 52 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.41600918 |
| 53 | regulation of skeletal muscle contraction (GO:0014819) | 3.41437506 |
| 54 | locomotory exploration behavior (GO:0035641) | 3.39502126 |
| 55 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.38994563 |
| 56 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.36294064 |
| 57 | neuromuscular synaptic transmission (GO:0007274) | 3.33366868 |
| 58 | cellular potassium ion homeostasis (GO:0030007) | 3.28973461 |
| 59 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.26974183 |
| 60 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.26465158 |
| 61 | apical protein localization (GO:0045176) | 3.23312099 |
| 62 | Rap protein signal transduction (GO:0032486) | 3.22821838 |
| 63 | protein palmitoylation (GO:0018345) | 3.21252527 |
| 64 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.20782773 |
| 65 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.20356641 |
| 66 | skeletal muscle contraction (GO:0003009) | 3.19437639 |
| 67 | regulation of synaptic vesicle transport (GO:1902803) | 3.19379360 |
| 68 | amyloid precursor protein metabolic process (GO:0042982) | 3.17289573 |
| 69 | potassium ion import (GO:0010107) | 3.15853723 |
| 70 | positive regulation of action potential (GO:0045760) | 3.15778738 |
| 71 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.15501826 |
| 72 | peripheral nervous system development (GO:0007422) | 3.14265286 |
| 73 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.14139750 |
| 74 | response to lipoprotein particle (GO:0055094) | 3.13714923 |
| 75 | positive regulation of neurological system process (GO:0031646) | 3.11363077 |
| 76 | nucleotide transmembrane transport (GO:1901679) | 3.09444356 |
| 77 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.05949696 |
| 78 | membrane depolarization during action potential (GO:0086010) | 3.03790323 |
| 79 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.01974904 |
| 80 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.98582674 |
| 81 | adult walking behavior (GO:0007628) | 2.98413144 |
| 82 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.96809307 |
| 83 | establishment of mitochondrion localization (GO:0051654) | 2.96795216 |
| 84 | very long-chain fatty acid metabolic process (GO:0000038) | 2.95526077 |
| 85 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.95502646 |
| 86 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.95129077 |
| 87 | positive regulation of synapse maturation (GO:0090129) | 2.95119436 |
| 88 | synaptic transmission, glutamatergic (GO:0035249) | 2.93612584 |
| 89 | striated muscle contraction (GO:0006941) | 2.92982276 |
| 90 | sodium ion export (GO:0071436) | 2.92706903 |
| 91 | neurotransmitter secretion (GO:0007269) | 2.91077144 |
| 92 | actin-mediated cell contraction (GO:0070252) | 2.88692179 |
| 93 | cerebellar granule cell differentiation (GO:0021707) | 2.86786113 |
| 94 | response to inactivity (GO:0014854) | 2.85233471 |
| 95 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.85073528 |
| 96 | limb bud formation (GO:0060174) | 2.84763686 |
| 97 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.84738844 |
| 98 | vocalization behavior (GO:0071625) | 2.84433342 |
| 99 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.83353129 |
| 100 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.82046693 |
| 101 | glycosylceramide metabolic process (GO:0006677) | 2.80668760 |
| 102 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.79762319 |
| 103 | regulation of cell communication by electrical coupling (GO:0010649) | 2.78297283 |
| 104 | membrane tubulation (GO:0097320) | 2.77183455 |
| 105 | glial cell development (GO:0021782) | 2.74979397 |
| 106 | gamma-aminobutyric acid transport (GO:0015812) | 2.74871784 |
| 107 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.74801578 |
| 108 | neurotransmitter catabolic process (GO:0042135) | 2.73388312 |
| 109 | dendritic spine morphogenesis (GO:0060997) | 2.73267560 |
| 110 | semaphorin-plexin signaling pathway (GO:0071526) | 2.72248137 |
| 111 | regulation of relaxation of muscle (GO:1901077) | 2.72115971 |
| 112 | * neural nucleus development (GO:0048857) | 2.72031010 |
| 113 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.71391984 |
| 114 | skeletal muscle fiber development (GO:0048741) | 2.70681901 |
| 115 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.70227990 |
| 116 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.68353645 |
| 117 | astrocyte differentiation (GO:0048708) | 2.65497208 |
| 118 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.65206269 |
| 119 | thioester biosynthetic process (GO:0035384) | 2.63360432 |
| 120 | acyl-CoA biosynthetic process (GO:0071616) | 2.63360432 |
| 121 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.62291975 |
| 122 | negative regulation of myoblast differentiation (GO:0045662) | 2.61489810 |
| 123 | neuron remodeling (GO:0016322) | 2.61162319 |
| 124 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.61123182 |
| 125 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.60614952 |
| 126 | regulation of synapse maturation (GO:0090128) | 2.59539796 |
| 127 | potassium ion homeostasis (GO:0055075) | 2.58909601 |
| 128 | glial cell differentiation (GO:0010001) | 2.58811840 |
| 129 | neuronal action potential propagation (GO:0019227) | 2.57383968 |
| 130 | membrane assembly (GO:0071709) | 2.55789481 |
| 131 | amyloid precursor protein catabolic process (GO:0042987) | 2.55660857 |
| 132 | peptidyl-cysteine modification (GO:0018198) | 2.55498059 |
| 133 | positive regulation of interleukin-17 production (GO:0032740) | 2.55397492 |
| 134 | negative regulation of JUN kinase activity (GO:0043508) | 2.54377050 |
| 135 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.53710744 |
| 136 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.53330069 |
| 137 | exploration behavior (GO:0035640) | 2.52964330 |
| 138 | dendrite morphogenesis (GO:0048813) | 2.52405228 |
| 139 | regulation of membrane repolarization (GO:0060306) | 2.51867491 |
| 140 | cardiac muscle contraction (GO:0060048) | 2.50751272 |
| 141 | auditory behavior (GO:0031223) | 2.50699834 |
| 142 | enteric nervous system development (GO:0048484) | 2.50032289 |
| 143 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.49949373 |
| 144 | nerve growth factor signaling pathway (GO:0038180) | 2.49910844 |
| 145 | regulation of neurotransmitter levels (GO:0001505) | 2.49636221 |
| 146 | magnesium ion transport (GO:0015693) | 2.49574539 |
| 147 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.48910853 |
| 148 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.48910853 |
| 149 | positive regulation of dendritic spine development (GO:0060999) | 2.47555532 |
| 150 | neurotransmitter uptake (GO:0001504) | 2.47201924 |
| 151 | actin filament depolymerization (GO:0030042) | 2.46456607 |
| 152 | axon development (GO:0061564) | 2.44669081 |
| 153 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.42743609 |
| 154 | myotube cell development (GO:0014904) | 2.42539571 |
| 155 | glutamate receptor signaling pathway (GO:0007215) | 2.42215483 |
| 156 | regulation of neurotransmitter secretion (GO:0046928) | 2.41417553 |
| 157 | L-glutamate transport (GO:0015813) | 2.41013985 |
| 158 | neuron-neuron synaptic transmission (GO:0007270) | 2.40685736 |
| 159 | regulation of neurotransmitter transport (GO:0051588) | 2.38883670 |
| 160 | myofibril assembly (GO:0030239) | 2.38575388 |
| 161 | acidic amino acid transport (GO:0015800) | 2.38130738 |
| 162 | regulation of neuron projection regeneration (GO:0070570) | 2.37825692 |
| 163 | regulation of axon regeneration (GO:0048679) | 2.37825692 |
| 164 | Golgi to plasma membrane protein transport (GO:0043001) | 2.37476256 |
| 165 | membrane depolarization (GO:0051899) | 2.37257962 |
| 166 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.37246739 |
| 167 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.37246739 |
| 168 | * peripheral nervous system axon ensheathment (GO:0032292) | 2.36768475 |
| 169 | * myelination in peripheral nervous system (GO:0022011) | 2.36768475 |
| 170 | membrane protein ectodomain proteolysis (GO:0006509) | 2.36405918 |
| 171 | neuron recognition (GO:0008038) | 2.36057234 |
| 172 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.35959106 |
| 173 | neurotransmitter transport (GO:0006836) | 2.35487315 |
| 174 | positive regulation of membrane potential (GO:0045838) | 2.34212914 |
| 175 | ear development (GO:0043583) | 2.33892742 |
| 176 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.33576291 |
| 177 | calcium ion-dependent exocytosis (GO:0017156) | 2.33234298 |
| 178 | negative regulation of cell morphogenesis involved in differentiation (GO:0010771) | 2.31137934 |
| 179 | response to muscle activity (GO:0014850) | 2.30293919 |
| 180 | ceramide biosynthetic process (GO:0046513) | 2.30279293 |
| 181 | negative regulation of neuron projection development (GO:0010977) | 2.27765515 |
| 182 | nucleotide transport (GO:0006862) | 2.26566127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.02737026 |
| 2 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.77841636 |
| 3 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.72298862 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.66570526 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.60784251 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.52247490 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.37836815 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.34689804 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.30617555 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.27012636 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.19751338 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.10530970 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.10474615 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.03870708 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.01630297 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.96558550 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.96558550 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.95757755 |
| 19 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.94684974 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.93139719 |
| 21 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.92616511 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.91076200 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.88719128 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84443225 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.83119058 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.80863751 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.80135830 |
| 28 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.79541510 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.76269068 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.70939643 |
| 31 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70461630 |
| 32 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.69060279 |
| 33 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68079230 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67318859 |
| 35 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.66915190 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.65754709 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.63612284 |
| 38 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.63181072 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58582493 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.56442103 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54871117 |
| 42 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.53266947 |
| 43 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.50685151 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.50572685 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41435355 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41367388 |
| 47 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39199727 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38422736 |
| 49 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37495517 |
| 50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.35189660 |
| 51 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32261504 |
| 52 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.31753610 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29964228 |
| 54 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.29932279 |
| 55 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.29409993 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29111642 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28991873 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28991873 |
| 59 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28580527 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27980500 |
| 61 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26962697 |
| 62 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26818931 |
| 63 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25403072 |
| 64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24252378 |
| 65 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.22103611 |
| 66 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20830895 |
| 67 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20482260 |
| 68 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.19972414 |
| 69 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19156251 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 1.16327204 |
| 71 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.15680628 |
| 72 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.14693446 |
| 73 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13933193 |
| 74 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.13801919 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12465915 |
| 76 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12464256 |
| 77 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.12089159 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10688309 |
| 79 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10447373 |
| 80 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08441703 |
| 81 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07574769 |
| 82 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07524212 |
| 83 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07265787 |
| 84 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.06986584 |
| 85 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06969318 |
| 86 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06888376 |
| 87 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06533747 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06508712 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06028544 |
| 90 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.05837536 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05652953 |
| 92 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05133871 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05006452 |
| 94 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.04962389 |
| 95 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04123872 |
| 96 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03449292 |
| 97 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03226076 |
| 98 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.01379196 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00629819 |
| 100 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.99445060 |
| 101 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98752302 |
| 102 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98696918 |
| 103 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97728004 |
| 104 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97403094 |
| 105 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.97081204 |
| 106 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.96488643 |
| 107 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95608282 |
| 108 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95086118 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94850151 |
| 110 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94603608 |
| 111 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.94501921 |
| 112 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94469433 |
| 113 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.94109621 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94040994 |
| 115 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.93762111 |
| 116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92916832 |
| 117 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92625675 |
| 118 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91665295 |
| 119 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91522424 |
| 120 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91219690 |
| 121 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91172662 |
| 122 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90637406 |
| 123 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90637406 |
| 124 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.90636945 |
| 125 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.89991703 |
| 126 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.89525743 |
| 127 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89366641 |
| 128 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89240341 |
| 129 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.88587549 |
| 130 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.88387800 |
| 131 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88190922 |
| 132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87629937 |
| 133 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86818304 |
| 134 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.86779794 |
| 135 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.86659783 |
| 136 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.86348368 |
| 137 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85842696 |
| 138 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.85566521 |
| 139 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84780550 |
| 140 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.84734279 |
| 141 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.84662147 |
| 142 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84643109 |
| 143 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.84443183 |
| 144 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.84033918 |
| 145 | TBL1_22424771_ChIP-Seq_293T_Human | 0.83733943 |
| 146 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.83511035 |
| 147 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.83450361 |
| 148 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83098860 |
| 149 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.83052307 |
| 150 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82567938 |
| 151 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.82435755 |
| 152 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.80726136 |
| 153 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.79638520 |
| 154 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.79299675 |
| 155 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79028964 |
| 156 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78654646 |
| 157 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.77796560 |
| 158 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.77337193 |
| 159 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.75107212 |
| 160 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.75034052 |
| 161 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.74881372 |
| 162 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.74447538 |
| 163 | * ERA_21632823_ChIP-Seq_H3396_Human | 0.73718173 |
| 164 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.73116210 |
| 165 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72847141 |
| 166 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.72480127 |
| 167 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.71972319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.69918695 |
| 2 | MP0003690_abnormal_glial_cell | 3.87564371 |
| 3 | MP0003880_abnormal_central_pattern | 3.86431673 |
| 4 | MP0003646_muscle_fatigue | 3.24616183 |
| 5 | MP0004742_abnormal_vestibular_system | 3.11772808 |
| 6 | MP0004270_analgesia | 2.85269511 |
| 7 | MP0004885_abnormal_endolymph | 2.84254468 |
| 8 | MP0005171_absent_coat_pigmentation | 2.72976841 |
| 9 | MP0001529_abnormal_vocalization | 2.70658004 |
| 10 | MP0003329_amyloid_beta_deposits | 2.66857631 |
| 11 | MP0003634_abnormal_glial_cell | 2.61004489 |
| 12 | MP0002272_abnormal_nervous_system | 2.52698676 |
| 13 | MP0001905_abnormal_dopamine_level | 2.46479601 |
| 14 | MP0001486_abnormal_startle_reflex | 2.45849074 |
| 15 | MP0002064_seizures | 2.40758948 |
| 16 | MP0000751_myopathy | 2.39171617 |
| 17 | MP0000778_abnormal_nervous_system | 2.38096833 |
| 18 | MP0004859_abnormal_synaptic_plasticity | 2.36572567 |
| 19 | MP0001485_abnormal_pinna_reflex | 2.36266883 |
| 20 | MP0003136_yellow_coat_color | 2.30881653 |
| 21 | MP0004130_abnormal_muscle_cell | 2.29219870 |
| 22 | MP0003950_abnormal_plasma_membrane | 2.23965227 |
| 23 | MP0003879_abnormal_hair_cell | 2.12064890 |
| 24 | MP0004142_abnormal_muscle_tone | 2.09635101 |
| 25 | MP0005167_abnormal_blood-brain_barrier | 1.95030035 |
| 26 | MP0000462_abnormal_digestive_system | 1.90379528 |
| 27 | MP0003632_abnormal_nervous_system | 1.90016338 |
| 28 | MP0009046_muscle_twitch | 1.87574552 |
| 29 | MP0009745_abnormal_behavioral_response | 1.87227396 |
| 30 | MP0002229_neurodegeneration | 1.86204312 |
| 31 | MP0004134_abnormal_chest_morphology | 1.84547206 |
| 32 | MP0003635_abnormal_synaptic_transmissio | 1.81012863 |
| 33 | MP0005409_darkened_coat_color | 1.76157761 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.70671020 |
| 35 | MP0001440_abnormal_grooming_behavior | 1.70063007 |
| 36 | MP0005451_abnormal_body_composition | 1.69368580 |
| 37 | MP0005410_abnormal_fertilization | 1.61763554 |
| 38 | MP0002734_abnormal_mechanical_nocicepti | 1.61247078 |
| 39 | MP0004510_myositis | 1.51085175 |
| 40 | MP0000604_amyloidosis | 1.50975539 |
| 41 | MP0000955_abnormal_spinal_cord | 1.48869890 |
| 42 | MP0002882_abnormal_neuron_morphology | 1.47953996 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.47185635 |
| 44 | MP0005623_abnormal_meninges_morphology | 1.46688914 |
| 45 | MP0005423_abnormal_somatic_nervous | 1.45205507 |
| 46 | MP0002572_abnormal_emotion/affect_behav | 1.44708295 |
| 47 | MP0002106_abnormal_muscle_physiology | 1.43938645 |
| 48 | MP0002822_catalepsy | 1.42251207 |
| 49 | MP0004145_abnormal_muscle_electrophysio | 1.38659319 |
| 50 | MP0004381_abnormal_hair_follicle | 1.36829734 |
| 51 | MP0001299_abnormal_eye_distance/ | 1.34334763 |
| 52 | MP0000759_abnormal_skeletal_muscle | 1.33556416 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.33296673 |
| 54 | MP0002653_abnormal_ependyma_morphology | 1.31761270 |
| 55 | MP0008569_lethality_at_weaning | 1.31663753 |
| 56 | MP0002063_abnormal_learning/memory/cond | 1.30848135 |
| 57 | MP0006276_abnormal_autonomic_nervous | 1.29801767 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.28271457 |
| 59 | MP0002066_abnormal_motor_capabilities/c | 1.28247212 |
| 60 | MP0003631_nervous_system_phenotype | 1.26678763 |
| 61 | MP0001963_abnormal_hearing_physiology | 1.24182931 |
| 62 | MP0004147_increased_porphyrin_level | 1.24146543 |
| 63 | MP0000383_abnormal_hair_follicle | 1.22949336 |
| 64 | MP0005620_abnormal_muscle_contractility | 1.22880327 |
| 65 | MP0002090_abnormal_vision | 1.22382767 |
| 66 | MP0002752_abnormal_somatic_nervous | 1.19928908 |
| 67 | MP0010678_abnormal_skin_adnexa | 1.18803809 |
| 68 | MP0005670_abnormal_white_adipose | 1.18743973 |
| 69 | MP0005369_muscle_phenotype | 1.17740230 |
| 70 | MP0000747_muscle_weakness | 1.16370954 |
| 71 | MP0004924_abnormal_behavior | 1.15748200 |
| 72 | MP0005386_behavior/neurological_phenoty | 1.15748200 |
| 73 | MP0002837_dystrophic_cardiac_calcinosis | 1.15571187 |
| 74 | MP0003075_altered_response_to | 1.13765524 |
| 75 | MP0001970_abnormal_pain_threshold | 1.13499754 |
| 76 | MP0004087_abnormal_muscle_fiber | 1.13178812 |
| 77 | MP0005058_abnormal_lysosome_morphology | 1.11876392 |
| 78 | MP0001661_extended_life_span | 1.11094813 |
| 79 | MP0002269_muscular_atrophy | 1.09745813 |
| 80 | MP0009840_abnormal_foam_cell | 1.08679346 |
| 81 | MP0002733_abnormal_thermal_nociception | 1.08605966 |
| 82 | MP0000750_abnormal_muscle_regeneration | 1.08375789 |
| 83 | MP0003137_abnormal_impulse_conducting | 1.06095880 |
| 84 | MP0003633_abnormal_nervous_system | 1.04255180 |
| 85 | MP0004215_abnormal_myocardial_fiber | 1.00910809 |
| 86 | MP0009780_abnormal_chondrocyte_physiolo | 1.00763488 |
| 87 | MP0005535_abnormal_body_temperature | 0.99413552 |
| 88 | MP0005195_abnormal_posterior_eye | 0.98591784 |
| 89 | MP0002295_abnormal_pulmonary_circulatio | 0.98291742 |
| 90 | MP0001968_abnormal_touch/_nociception | 0.96178790 |
| 91 | MP0002876_abnormal_thyroid_physiology | 0.93659775 |
| 92 | MP0002972_abnormal_cardiac_muscle | 0.93052170 |
| 93 | MP0004484_altered_response_of | 0.92740847 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.92580612 |
| 95 | MP0004084_abnormal_cardiac_muscle | 0.91656427 |
| 96 | MP0008874_decreased_physiological_sensi | 0.88911379 |
| 97 | MP0006036_abnormal_mitochondrial_physio | 0.87951998 |
| 98 | MP0002638_abnormal_pupillary_reflex | 0.86849053 |
| 99 | MP0005408_hypopigmentation | 0.86343850 |
| 100 | MP0003938_abnormal_ear_development | 0.85999924 |
| 101 | MP0003806_abnormal_nucleotide_metabolis | 0.85931092 |
| 102 | MP0001177_atelectasis | 0.84668232 |
| 103 | MP0002736_abnormal_nociception_after | 0.83686086 |
| 104 | MP0002152_abnormal_brain_morphology | 0.83619857 |
| 105 | MP0005253_abnormal_eye_physiology | 0.83562133 |
| 106 | MP0003195_calcinosis | 0.82172575 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.82086216 |
| 108 | MP0004043_abnormal_pH_regulation | 0.81764378 |
| 109 | MP0006082_CNS_inflammation | 0.80155025 |
| 110 | MP0001984_abnormal_olfaction | 0.80031308 |
| 111 | MP0000647_abnormal_sebaceous_gland | 0.78755368 |
| 112 | MP0000343_altered_response_to | 0.77852106 |
| 113 | MP0001851_eye_inflammation | 0.77315879 |
| 114 | MP0000026_abnormal_inner_ear | 0.76594887 |
| 115 | MP0000467_abnormal_esophagus_morphology | 0.75596567 |
| 116 | MP0002184_abnormal_innervation | 0.74377034 |
| 117 | MP0005166_decreased_susceptibility_to | 0.73769308 |
| 118 | MP0002735_abnormal_chemical_nociception | 0.73767295 |
| 119 | MP0005310_abnormal_salivary_gland | 0.73532314 |
| 120 | MP0003787_abnormal_imprinting | 0.73504652 |
| 121 | MP0002971_abnormal_brown_adipose | 0.72683118 |
| 122 | MP0002557_abnormal_social/conspecific_i | 0.71824205 |
| 123 | MP0001346_abnormal_lacrimal_gland | 0.71307523 |
| 124 | MP0008438_abnormal_cutaneous_collagen | 0.71019308 |
| 125 | MP0000566_synostosis | 0.70537025 |
| 126 | MP0009384_cardiac_valve_regurgitation | 0.70050875 |
| 127 | MP0000762_abnormal_tongue_morphology | 0.69624643 |
| 128 | MP0003011_delayed_dark_adaptation | 0.69205774 |
| 129 | MP0000749_muscle_degeneration | 0.62079113 |
| 130 | MP0001501_abnormal_sleep_pattern | 0.61531379 |
| 131 | MP0004036_abnormal_muscle_relaxation | 0.61271943 |
| 132 | MP0004811_abnormal_neuron_physiology | 0.58418754 |
| 133 | MP0003937_abnormal_limbs/digits/tail_de | 0.57759837 |
| 134 | MP0001727_abnormal_embryo_implantation | 0.56221446 |
| 135 | MP0002133_abnormal_respiratory_system | 0.55859210 |
| 136 | MP0005388_respiratory_system_phenotype | 0.55859210 |
| 137 | MP0001502_abnormal_circadian_rhythm | 0.55491676 |
| 138 | MP0005646_abnormal_pituitary_gland | 0.55148190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.28113919 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.28113919 |
| 3 | Sensory axonal neuropathy (HP:0003390) | 5.98549234 |
| 4 | Neurofibrillary tangles (HP:0002185) | 5.86130200 |
| 5 | Muscle fiber inclusion bodies (HP:0100299) | 5.70437029 |
| 6 | Nemaline bodies (HP:0003798) | 5.59090026 |
| 7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.51246520 |
| 8 | Peripheral hypomyelination (HP:0007182) | 4.79644679 |
| 9 | Abnormality of the corticospinal tract (HP:0002492) | 4.78124154 |
| 10 | Exercise-induced myalgia (HP:0003738) | 4.62891086 |
| 11 | Parakeratosis (HP:0001036) | 4.53586978 |
| 12 | Type 1 muscle fiber predominance (HP:0003803) | 4.43001204 |
| 13 | Cerebral inclusion bodies (HP:0100314) | 4.05306893 |
| 14 | Cerebral hypomyelination (HP:0006808) | 4.00674584 |
| 15 | Muscle fiber splitting (HP:0003555) | 3.90544623 |
| 16 | Akinesia (HP:0002304) | 3.85689362 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 3.78554334 |
| 18 | Focal motor seizures (HP:0011153) | 3.75721148 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.75228992 |
| 20 | Exercise-induced muscle cramps (HP:0003710) | 3.63523604 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 3.61855921 |
| 22 | Intention tremor (HP:0002080) | 3.61582927 |
| 23 | Spastic gait (HP:0002064) | 3.54514479 |
| 24 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.54403207 |
| 25 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.46336652 |
| 26 | Myopathic facies (HP:0002058) | 3.44296880 |
| 27 | Premature skin wrinkling (HP:0100678) | 3.39069075 |
| 28 | Alacrima (HP:0000522) | 3.36886932 |
| 29 | Round ear (HP:0100830) | 3.36154060 |
| 30 | Distal arthrogryposis (HP:0005684) | 3.33994129 |
| 31 | Onion bulb formation (HP:0003383) | 3.31238620 |
| 32 | Abnormality of glycolysis (HP:0004366) | 3.31107006 |
| 33 | Increased serum pyruvate (HP:0003542) | 3.31107006 |
| 34 | Dysmetria (HP:0001310) | 3.18107546 |
| 35 | Calf muscle hypertrophy (HP:0008981) | 3.15532689 |
| 36 | Abnormality of binocular vision (HP:0011514) | 3.15393304 |
| 37 | Diplopia (HP:0000651) | 3.15393304 |
| 38 | Abnormal auditory evoked potentials (HP:0006958) | 3.10420922 |
| 39 | Focal seizures (HP:0007359) | 3.09562133 |
| 40 | Leukodystrophy (HP:0002415) | 3.02913959 |
| 41 | Spastic paraparesis (HP:0002313) | 3.00352063 |
| 42 | Bundle branch block (HP:0011710) | 2.95553065 |
| 43 | Frequent falls (HP:0002359) | 2.93214357 |
| 44 | Slow saccadic eye movements (HP:0000514) | 2.91490813 |
| 45 | Atonic seizures (HP:0010819) | 2.78678906 |
| 46 | Termporal pattern (HP:0011008) | 2.72827075 |
| 47 | Insidious onset (HP:0003587) | 2.72827075 |
| 48 | Asymmetric septal hypertrophy (HP:0001670) | 2.71711877 |
| 49 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.71583810 |
| 50 | Decreased lacrimation (HP:0000633) | 2.71529001 |
| 51 | Hypoplastic pelvis (HP:0008839) | 2.69218616 |
| 52 | Abnormality of the calf musculature (HP:0001430) | 2.68533165 |
| 53 | Myoglobinuria (HP:0002913) | 2.67936706 |
| 54 | Increased circulating renin level (HP:0000848) | 2.67516669 |
| 55 | Retinal dysplasia (HP:0007973) | 2.67219313 |
| 56 | Scanning speech (HP:0002168) | 2.65284022 |
| 57 | Mutism (HP:0002300) | 2.63700206 |
| 58 | Small epiphyses (HP:0010585) | 2.62416554 |
| 59 | Difficulty running (HP:0009046) | 2.61306321 |
| 60 | Abnormal eating behavior (HP:0100738) | 2.58249794 |
| 61 | Visual hallucinations (HP:0002367) | 2.57547439 |
| 62 | Clumsiness (HP:0002312) | 2.56240103 |
| 63 | Ulnar deviation of the wrist (HP:0003049) | 2.55911495 |
| 64 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.55492983 |
| 65 | Rhabdomyolysis (HP:0003201) | 2.54782542 |
| 66 | Sudden death (HP:0001699) | 2.54414771 |
| 67 | Hemiplegia (HP:0002301) | 2.54128512 |
| 68 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.52855974 |
| 69 | Myotonia (HP:0002486) | 2.50115206 |
| 70 | Febrile seizures (HP:0002373) | 2.50071177 |
| 71 | Neck muscle weakness (HP:0000467) | 2.48983923 |
| 72 | Increased variability in muscle fiber diameter (HP:0003557) | 2.45375506 |
| 73 | Weak cry (HP:0001612) | 2.44398056 |
| 74 | White forelock (HP:0002211) | 2.40115003 |
| 75 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.39975363 |
| 76 | Polyphagia (HP:0002591) | 2.39142555 |
| 77 | Stridor (HP:0010307) | 2.37553118 |
| 78 | Cerebral hemorrhage (HP:0001342) | 2.36534053 |
| 79 | Renal Fanconi syndrome (HP:0001994) | 2.35844779 |
| 80 | Morphological abnormality of the inner ear (HP:0011390) | 2.34677645 |
| 81 | Partial agenesis of the corpus callosum (HP:0001338) | 2.33353362 |
| 82 | EMG: neuropathic changes (HP:0003445) | 2.31508522 |
| 83 | Heart block (HP:0012722) | 2.29730184 |
| 84 | Patchy hypopigmentation of hair (HP:0011365) | 2.29279148 |
| 85 | Abnormality of the parathyroid morphology (HP:0011766) | 2.26406336 |
| 86 | Pheochromocytoma (HP:0002666) | 2.25553715 |
| 87 | Gowers sign (HP:0003391) | 2.24447047 |
| 88 | Myokymia (HP:0002411) | 2.23535644 |
| 89 | Postural instability (HP:0002172) | 2.22116420 |
| 90 | Generalized tonic-clonic seizures (HP:0002069) | 2.21900368 |
| 91 | Adrenal hypoplasia (HP:0000835) | 2.21701277 |
| 92 | Hypomagnesemia (HP:0002917) | 2.21625443 |
| 93 | Ankle clonus (HP:0011448) | 2.20312186 |
| 94 | Bulbar palsy (HP:0001283) | 2.16976991 |
| 95 | CNS hypomyelination (HP:0003429) | 2.16835935 |
| 96 | Hepatosplenomegaly (HP:0001433) | 2.16704033 |
| 97 | Paraparesis (HP:0002385) | 2.14604732 |
| 98 | Epileptic encephalopathy (HP:0200134) | 2.14239517 |
| 99 | Abnormal atrioventricular conduction (HP:0005150) | 2.13796608 |
| 100 | Subaortic stenosis (HP:0001682) | 2.11129465 |
| 101 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.11129465 |
| 102 | Progressive cerebellar ataxia (HP:0002073) | 2.10993245 |
| 103 | Foot dorsiflexor weakness (HP:0009027) | 2.10455501 |
| 104 | Malignant hyperthermia (HP:0002047) | 2.09732913 |
| 105 | Thickened helices (HP:0000391) | 2.09656029 |
| 106 | Anomalous pulmonary venous return (HP:0010772) | 2.08639774 |
| 107 | Distal lower limb muscle weakness (HP:0009053) | 2.08446244 |
| 108 | Absent septum pellucidum (HP:0001331) | 2.08216168 |
| 109 | Anteriorly placed anus (HP:0001545) | 2.08197090 |
| 110 | Muscle stiffness (HP:0003552) | 2.07164836 |
| 111 | Generalized muscle weakness (HP:0003324) | 2.06010787 |
| 112 | Generalized myoclonic seizures (HP:0002123) | 2.05516939 |
| 113 | Rapidly progressive (HP:0003678) | 2.05475721 |
| 114 | Ventricular fibrillation (HP:0001663) | 2.05461223 |
| 115 | Lower limb muscle weakness (HP:0007340) | 2.05084659 |
| 116 | Diminished movement (HP:0002374) | 2.04582448 |
| 117 | Abolished electroretinogram (ERG) (HP:0000550) | 2.04500261 |
| 118 | Rigidity (HP:0002063) | 2.04411625 |
| 119 | Spastic tetraparesis (HP:0001285) | 2.04229242 |
| 120 | Hemiparesis (HP:0001269) | 2.04156581 |
| 121 | Abnormality of the foot musculature (HP:0001436) | 2.01537290 |
| 122 | Limb dystonia (HP:0002451) | 1.99644325 |
| 123 | Fatigable weakness (HP:0003473) | 1.98356389 |
| 124 | Abnormality of the neuromuscular junction (HP:0003398) | 1.98356389 |
| 125 | Type 2 muscle fiber atrophy (HP:0003554) | 1.98257455 |
| 126 | Bowel incontinence (HP:0002607) | 1.97920759 |
| 127 | Neuroendocrine neoplasm (HP:0100634) | 1.97770129 |
| 128 | Prolonged QT interval (HP:0001657) | 1.97512937 |
| 129 | Hypoplasia of the iris (HP:0007676) | 1.97389137 |
| 130 | Action tremor (HP:0002345) | 1.96310850 |
| 131 | Coronal craniosynostosis (HP:0004440) | 1.95262685 |
| 132 | Split foot (HP:0001839) | 1.94030014 |
| 133 | Poor speech (HP:0002465) | 1.92620092 |
| 134 | Cupped ear (HP:0000378) | 1.92566254 |
| 135 | Autoamputation (HP:0001218) | 1.89835824 |
| 136 | Obstructive sleep apnea (HP:0002870) | 1.89562996 |
| 137 | Aplasia involving bones of the extremities (HP:0009825) | 1.89383980 |
| 138 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.89383980 |
| 139 | Aplasia of the phalanges of the hand (HP:0009802) | 1.89383980 |
| 140 | Infantile muscular hypotonia (HP:0008947) | 1.88808841 |
| 141 | Abnormal EKG (HP:0003115) | 1.87913626 |
| 142 | Metabolic alkalosis (HP:0200114) | 1.86207081 |
| 143 | Epiphyseal dysplasia (HP:0002656) | 1.84880149 |
| 144 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.84731718 |
| 145 | Barrel-shaped chest (HP:0001552) | 1.84087625 |
| 146 | Delusions (HP:0000746) | 1.84023840 |
| 147 | Fetal akinesia sequence (HP:0001989) | 1.83406095 |
| 148 | Tetraplegia (HP:0002445) | 1.83091390 |
| 149 | Muscle fiber atrophy (HP:0100295) | 1.82900496 |
| 150 | Abnormal large intestine physiology (HP:0012700) | 1.82062774 |
| 151 | Absent phalangeal crease (HP:0006109) | 1.81542103 |
| 152 | Esophageal atresia (HP:0002032) | 1.78765050 |
| 153 | Ventricular arrhythmia (HP:0004308) | 1.77550851 |
| 154 | Neuronal loss in central nervous system (HP:0002529) | 1.77304725 |
| 155 | Nonprogressive disorder (HP:0003680) | 1.77025719 |
| 156 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.76785838 |
| 157 | Absence seizures (HP:0002121) | 1.73652967 |
| 158 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73533937 |
| 159 | Lower limb amyotrophy (HP:0007210) | 1.73533598 |
| 160 | Abnormality of the pulmonary veins (HP:0011718) | 1.72951646 |
| 161 | Rimmed vacuoles (HP:0003805) | 1.72709924 |
| 162 | Relative macrocephaly (HP:0004482) | 1.72154682 |
| 163 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.71751428 |
| 164 | Septo-optic dysplasia (HP:0100842) | 1.71245815 |
| 165 | Areflexia of lower limbs (HP:0002522) | 1.71175476 |
| 166 | Hypokalemic alkalosis (HP:0001949) | 1.70865925 |
| 167 | Abnormality of the vitreous humor (HP:0004327) | 1.69321287 |
| 168 | Steppage gait (HP:0003376) | 1.69028208 |
| 169 | Abnormality of the septum pellucidum (HP:0007375) | 1.68991102 |
| 170 | Acute necrotizing encephalopathy (HP:0006965) | 1.68766941 |
| 171 | Megalencephaly (HP:0001355) | 1.68611945 |
| 172 | Dysdiadochokinesis (HP:0002075) | 1.68110309 |
| 173 | Abnormality of magnesium homeostasis (HP:0004921) | 1.66766740 |
| 174 | Urinary incontinence (HP:0000020) | 1.66520808 |
| 175 | Synostosis involving the elbow (HP:0003938) | 1.66096115 |
| 176 | Humeroradial synostosis (HP:0003041) | 1.66096115 |
| 177 | Thick nail (HP:0001805) | 1.63774735 |
| 178 | Type II lissencephaly (HP:0007260) | 1.63519511 |
| 179 | Methylmalonic acidemia (HP:0002912) | 1.62021133 |
| 180 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.61921365 |
| 181 | Chin dimple (HP:0010751) | 1.61336423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.98149227 |
| 2 | TNIK | 4.41059601 |
| 3 | OXSR1 | 4.04984201 |
| 4 | EPHB1 | 3.66848760 |
| 5 | PRPF4B | 3.04345104 |
| 6 | TYRO3 | 2.88264451 |
| 7 | PKN1 | 2.60478814 |
| 8 | BCR | 2.59812192 |
| 9 | WNK4 | 2.52419678 |
| 10 | DAPK2 | 2.46754389 |
| 11 | ICK | 2.42306052 |
| 12 | PINK1 | 2.06064881 |
| 13 | UHMK1 | 2.00349746 |
| 14 | MAP3K11 | 1.99320938 |
| 15 | FES | 1.98599568 |
| 16 | PBK | 1.97457236 |
| 17 | CDK19 | 1.96072289 |
| 18 | NEK6 | 1.94106718 |
| 19 | MET | 1.88014580 |
| 20 | LIMK1 | 1.81050292 |
| 21 | PRKD3 | 1.74867090 |
| 22 | IRAK2 | 1.72998685 |
| 23 | MAPK12 | 1.68451949 |
| 24 | WNK1 | 1.65959620 |
| 25 | FGFR2 | 1.62860172 |
| 26 | CASK | 1.58118520 |
| 27 | TNK2 | 1.56742123 |
| 28 | ROCK2 | 1.55280175 |
| 29 | TTN | 1.46156748 |
| 30 | NTRK1 | 1.45970093 |
| 31 | RIPK4 | 1.45898114 |
| 32 | CSNK1G3 | 1.45552069 |
| 33 | CAMKK1 | 1.38360245 |
| 34 | MAPKAPK5 | 1.37545306 |
| 35 | SIK2 | 1.36140692 |
| 36 | CSNK1A1L | 1.35440927 |
| 37 | FGR | 1.34434735 |
| 38 | IRAK1 | 1.33910505 |
| 39 | EPHA4 | 1.33506082 |
| 40 | TESK1 | 1.31197192 |
| 41 | PAK6 | 1.26103785 |
| 42 | CLK1 | 1.18926716 |
| 43 | MST4 | 1.17860822 |
| 44 | MAPK13 | 1.15731995 |
| 45 | CAMK1 | 1.15728920 |
| 46 | PNCK | 1.12148206 |
| 47 | CSNK1G2 | 1.07027407 |
| 48 | CAMK2D | 1.05430504 |
| 49 | CSNK1G1 | 1.04765350 |
| 50 | CAMKK2 | 1.04646069 |
| 51 | CAMK2B | 1.04502567 |
| 52 | PIK3CG | 1.00215150 |
| 53 | PRKCQ | 0.99408067 |
| 54 | DDR2 | 0.97002648 |
| 55 | IRAK4 | 0.93037091 |
| 56 | MOS | 0.91466056 |
| 57 | SGK223 | 0.91110811 |
| 58 | SGK494 | 0.91110811 |
| 59 | MAPKAPK3 | 0.90931192 |
| 60 | MARK1 | 0.89436566 |
| 61 | GRK5 | 0.89231517 |
| 62 | CSK | 0.88372054 |
| 63 | PDGFRB | 0.84846136 |
| 64 | MAP2K4 | 0.81816112 |
| 65 | PAK3 | 0.80774307 |
| 66 | INSRR | 0.77758776 |
| 67 | CDK5 | 0.77185747 |
| 68 | MAP3K7 | 0.76703950 |
| 69 | DYRK2 | 0.76564913 |
| 70 | BCKDK | 0.74938381 |
| 71 | CDK14 | 0.74770748 |
| 72 | ROCK1 | 0.73422470 |
| 73 | PHKG2 | 0.72918056 |
| 74 | PHKG1 | 0.72918056 |
| 75 | FYN | 0.72205708 |
| 76 | TESK2 | 0.70970211 |
| 77 | BLK | 0.70606222 |
| 78 | MARK2 | 0.70582697 |
| 79 | CAMK2G | 0.69882412 |
| 80 | CAMK4 | 0.69105427 |
| 81 | MAPK15 | 0.68332096 |
| 82 | CAMK2A | 0.67986139 |
| 83 | DAPK3 | 0.66760471 |
| 84 | TRIB3 | 0.64898758 |
| 85 | MAP3K2 | 0.64115397 |
| 86 | TIE1 | 0.61205573 |
| 87 | PDPK1 | 0.60705262 |
| 88 | STK38 | 0.60652348 |
| 89 | MAP2K6 | 0.60624728 |
| 90 | DYRK1B | 0.59285675 |
| 91 | ARAF | 0.58381158 |
| 92 | CDC42BPA | 0.58114582 |
| 93 | CDK15 | 0.57279315 |
| 94 | PRKCZ | 0.57008749 |
| 95 | SGK2 | 0.56371112 |
| 96 | DMPK | 0.56308485 |
| 97 | EPHA3 | 0.54849835 |
| 98 | NTRK2 | 0.54762444 |
| 99 | SGK3 | 0.53722005 |
| 100 | PRKCE | 0.53660091 |
| 101 | CDK18 | 0.53304311 |
| 102 | ZAP70 | 0.52106344 |
| 103 | SYK | 0.51841831 |
| 104 | MAP2K1 | 0.51828588 |
| 105 | CDK11A | 0.51275687 |
| 106 | PRKD1 | 0.51269777 |
| 107 | PLK2 | 0.50292996 |
| 108 | INSR | 0.48959754 |
| 109 | RIPK1 | 0.48506411 |
| 110 | PRKCH | 0.47451639 |
| 111 | KSR2 | 0.47390035 |
| 112 | ERBB4 | 0.45544584 |
| 113 | MAP3K13 | 0.45266443 |
| 114 | SGK1 | 0.45022257 |
| 115 | MAP2K3 | 0.44417797 |
| 116 | TXK | 0.43322991 |
| 117 | DYRK1A | 0.41828347 |
| 118 | MAPK10 | 0.39403803 |
| 119 | GSK3A | 0.39193698 |
| 120 | PRKD2 | 0.39159462 |
| 121 | PRKG1 | 0.38872309 |
| 122 | MAP3K1 | 0.38690795 |
| 123 | MAP3K9 | 0.38441105 |
| 124 | PTK2 | 0.37551938 |
| 125 | MINK1 | 0.36161817 |
| 126 | GRK7 | 0.34527423 |
| 127 | PDK1 | 0.33953476 |
| 128 | CSNK1D | 0.32706811 |
| 129 | ITK | 0.29921783 |
| 130 | PIK3CA | 0.29179124 |
| 131 | PRKACA | 0.29177328 |
| 132 | LCK | 0.28555169 |
| 133 | MUSK | 0.28309648 |
| 134 | CSNK1A1 | 0.28180712 |
| 135 | SRC | 0.27771817 |
| 136 | PTK2B | 0.26893279 |
| 137 | PRKACB | 0.26387576 |
| 138 | STK11 | 0.26331252 |
| 139 | OBSCN | 0.25373619 |
| 140 | BMX | 0.23994735 |
| 141 | ADRBK2 | 0.23614862 |
| 142 | PRKCG | 0.22981245 |
| 143 | NTRK3 | 0.22754418 |
| 144 | ABL2 | 0.21155463 |
| 145 | MAPK7 | 0.20814799 |
| 146 | PAK1 | 0.18937084 |
| 147 | RET | 0.17867350 |
| 148 | NUAK1 | 0.17016331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.55412686 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.91543764 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.87264994 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.83776755 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.11313119 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.18351757 |
| 7 | Axon guidance_Homo sapiens_hsa04360 | 2.14607180 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.10183453 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.02260423 |
| 10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.94763313 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 1.86447066 |
| 12 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.81577386 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.76249270 |
| 14 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.65488116 |
| 15 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.61751404 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.61276906 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.57034664 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.56537700 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.53097723 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.42449436 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42289131 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.41921625 |
| 23 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.41312407 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.38513776 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.33068642 |
| 26 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.32354544 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.31583628 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.29295329 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.26504728 |
| 30 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.20799981 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18093750 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.15147152 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.13240117 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.13077755 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.12622758 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.10160075 |
| 37 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.09652092 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09305029 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06655755 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.06465159 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05508310 |
| 42 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.01400050 |
| 43 | Olfactory transduction_Homo sapiens_hsa04740 | 1.00611978 |
| 44 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.99678444 |
| 45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98733109 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98541321 |
| 47 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.97120730 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92136766 |
| 49 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.91345046 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.90356497 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 0.89279104 |
| 52 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.87961321 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85598051 |
| 54 | Morphine addiction_Homo sapiens_hsa05032 | 0.85597288 |
| 55 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.85405480 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.83725103 |
| 57 | Endocytosis_Homo sapiens_hsa04144 | 0.83161267 |
| 58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.82169703 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.81203226 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.77081847 |
| 61 | Tight junction_Homo sapiens_hsa04530 | 0.76726713 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76632633 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76157582 |
| 64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74179820 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73831971 |
| 66 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73113882 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71761287 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70374829 |
| 69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69154470 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.69083093 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69045052 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.68839904 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68398039 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68109967 |
| 75 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.67676137 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67415556 |
| 77 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.66046385 |
| 78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65991150 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.65075659 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64865944 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63916289 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.63909635 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62244364 |
| 84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62200321 |
| 85 | Huntingtons disease_Homo sapiens_hsa05016 | 0.61605502 |
| 86 | Circadian entrainment_Homo sapiens_hsa04713 | 0.61597677 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61309778 |
| 88 | Salivary secretion_Homo sapiens_hsa04970 | 0.61209035 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61153134 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.60897522 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59718004 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59222353 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58727805 |
| 94 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58054388 |
| 95 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57086768 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56952597 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56477723 |
| 98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56333937 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55816748 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54116931 |
| 101 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.53072932 |
| 102 | Malaria_Homo sapiens_hsa05144 | 0.51420353 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51364469 |
| 104 | Nicotine addiction_Homo sapiens_hsa05033 | 0.50043384 |
| 105 | Phototransduction_Homo sapiens_hsa04744 | 0.49928492 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49757963 |
| 107 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49275209 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48348055 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48097100 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47955657 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47825962 |
| 112 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47544646 |
| 113 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46650026 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44788353 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.44467571 |
| 116 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.44432827 |
| 117 | Gap junction_Homo sapiens_hsa04540 | 0.43802037 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43236225 |
| 119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42824053 |
| 120 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42526320 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42505375 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41763604 |
| 123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40052280 |
| 124 | Cocaine addiction_Homo sapiens_hsa05030 | 0.36664581 |
| 125 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.36140770 |
| 126 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33307738 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31827557 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.31231109 |
| 129 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.31030043 |
| 130 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.28693799 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28630887 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28327302 |
| 133 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27737126 |
| 134 | Mineral absorption_Homo sapiens_hsa04978 | 0.26857154 |
| 135 | Salmonella infection_Homo sapiens_hsa05132 | 0.26471590 |
| 136 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26257906 |
| 137 | Platelet activation_Homo sapiens_hsa04611 | 0.25747469 |
| 138 | Long-term potentiation_Homo sapiens_hsa04720 | 0.25159622 |
| 139 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.24809341 |
| 140 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.24749508 |
| 141 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.24356491 |

